{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:50:01Z","timestamp":1789023001329,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40256-026-00788-7","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:02:59Z","timestamp":1770991379000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cimlanod, a Second-Generation Nitroxyl Donor, in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis of Hemodynamic Efficacy and Safety Profile"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3580-0783","authenticated-orcid":false,"given":"Mrunalini","family":"Dandamudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh Q. T.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Samaniego-Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giang Son","family":"Arrighini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Chamay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemank","family":"Walia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana M.","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Barbagelata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"788_CR1","doi-asserted-by":"crossref","unstructured":"Tita C, Gilbert EM, Van Bakel AB, Grzybowski J, Haas GJ, Jarrah M, et al. A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction. Eur J Heart Fail. [Internet]. 2017 [cited 2025 Nov 5];19(10):1321\u201332. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ejhf.897.","DOI":"10.1002\/ejhf.897"},{"key":"788_CR2","doi-asserted-by":"crossref","unstructured":"Pellicori P, Cleland JGF, Borentain M, Taubel J, Graham FJ, Khan J, et al. Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS-986231). Eur J Heart Fail. [Internet]. 2024 [cited 2025 Nov 5];26(1):142\u201351. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ejhf.3077.","DOI":"10.1002\/ejhf.3077"},{"key":"788_CR3","doi-asserted-by":"crossref","unstructured":"Lang NN, Ahmad FA, Cleland JG, O\u2019Connor CM, Teerlink JR, Voors AA, et al. Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial. Eur J Heart Fail. [Internet]. 2021 [cited 2025 Nov 5];23(7):1147\u201355. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ejhf.2138.","DOI":"10.1002\/ejhf.2138"},{"key":"788_CR4","doi-asserted-by":"crossref","unstructured":"Felker GM, McMurray JJV, Cleland JG, O\u2019Connor CM, Teerlink JR, Voors AA, et al. Effects of a novel nitroxyl donor in acute heart failure: The STAND-UP AHF Study. JACC: Heart Fail. [Internet]. 2021 Feb 1 [cited 2025 Nov 5];9(2):146\u201357. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2213177920305904.","DOI":"10.1016\/j.jchf.2020.10.012"},{"key":"788_CR5","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ [Internet]. 2021 Mar 29 [cited 2025 Nov 5];372:n71. https:\/\/www.bmj.com\/content\/372\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"788_CR6","unstructured":"Deeks JJ, Higgins JP, Altman DG, McKenzie JE, Veroniki AA (editors). Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions version 6.5. Cochrane; 2024. Last updated November 2024. cochrane.org\/handbook."},{"key":"788_CR7","doi-asserted-by":"crossref","unstructured":"Cotter G, Moshkovitz Y, Kaluski E, Cohen AJ, Miller H, Goor D, et al. Accurate, noninvasive continuous monitoring of cardiac output by whole-body electrical bioimpedance. CHEST [Internet]. 2004 Apr 1 [cited 2025 Nov 5];125(4):1431\u201340. https:\/\/journal.chestnet.org\/article\/S0012-3692(15)32107-3\/abstract.","DOI":"10.1378\/chest.125.4.1431"},{"key":"788_CR8","doi-asserted-by":"crossref","unstructured":"Leitman M, Sucher E, Kaluski E, Wolf R, Peleg E, Moshkovitz Y, et al. Non-invasive measurement of cardiac output by whole-body bio-impedance during dobutamine stress echocardiography: clinical implications in patients with left ventricular dysfunction and ischaemia. Eur J Heart Fail. [Internet]. 2006 [cited 2025 Nov 5];8(2):136\u201340. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1016\/j.ejheart.2005.06.006.","DOI":"10.1016\/j.ejheart.2005.06.006"},{"issue":"9","key":"788_CR9","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1253\/circj.CJ-13-0172","volume":"77","author":"Y Taniguchi","year":"2013","unstructured":"Taniguchi Y, Emoto N, Miyagawa K, Nakayama K, Kinutani H, Tanaka H, et al. Noninvasive and simple assessment of cardiac output and pulmonary vascular resistance with whole-body impedance cardiography is useful for monitoring patients with pulmonary hypertension. Circ J. 2013;77(9):2383\u20139.","journal-title":"Circ J"},{"key":"788_CR10","doi-asserted-by":"crossref","unstructured":"Galas A, Krzesi\u0144ski P, Gielerak G, Piechota W, Uzi\u0119b\u0142o-\u017byczkowska B, Sta\u0144czyk A, et al. Complex assessment of patients with decompensated heart failure: the clinical value of impedance cardiography and N-terminal pro-brain natriuretic peptide. Heart Lung: J Cardiopulm Acute Care. [Internet]. 2019 July 1 [cited 2025 Nov 5];48(4):294\u2013301. https:\/\/www.heartandlung.org\/article\/S0147-9563(18)30290-5\/abstract.","DOI":"10.1016\/j.hrtlng.2018.10.004"},{"key":"788_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033943","author":"AS Vink","year":"2018","unstructured":"Vink AS, Neumann B, Lieve KVV, Sinner MF, Hofman N, el Kadi S, et al. Determination and interpretation of the QT interval: comprehensive analysis of a large cohort of long QT syndrome patients and controls. Circulation. 2018. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.033943.","journal-title":"Circulation"},{"key":"788_CR12","doi-asserted-by":"crossref","unstructured":"Tisdale JE, Chung MK, Campbell KB, Hammadah M, Joglar JA, Leclerc J, et al. Drug-induced arrhythmias: a scientific statement from the American Heart Association. Circulation. [Internet]. 2020 Oct 13 [cited 2025 Nov 6];142(15):e214\u201333. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000905.","DOI":"10.1161\/CIR.0000000000000905"},{"key":"788_CR13","unstructured":"Inotropes and Vasopressors [Internet]. The Cardiovascular. [cited 2025 Nov 6]. https:\/\/ecgwaves.com\/topic\/inotropes-and-vasopressors-doses-indications-contraindications-and-effects\/."},{"key":"788_CR14","doi-asserted-by":"crossref","unstructured":"Giudicessi JR, Noseworthy PA, Ackerman MJ. The QT interval. Circulation. [Internet]. 2019 June 11 [cited 2025 Nov 6];139(24):2711\u20133. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.119.039598.","DOI":"10.1161\/CIRCULATIONAHA.119.039598"},{"key":"788_CR15","unstructured":"Schwarzer G. meta: General package for meta-analysis [Internet]. 2025 [cited 2025 Nov 5]. https:\/\/cran.r-project.org\/web\/packages\/meta\/index.html."},{"key":"788_CR16","unstructured":"Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Welcome! | Doing meta-analysis in R [Internet]. [cited 2025 Nov 5]. https:\/\/ng-meta.guide\/."},{"key":"788_CR17","doi-asserted-by":"crossref","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics\u20142021 update. Circulation. [Internet]. 2021 Feb 23 [cited 2025 Nov 5];143(8):e254\u2013743. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000950.","DOI":"10.1161\/CIR.0000000000000950"},{"key":"788_CR18","unstructured":"Savarese G, Lund LH. Global public health burden of heart failure. Cardiac Fail Rev. [Internet]. 2017 Apr [cited 2025 Nov 5];3(1):7\u201311. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5494150\/."},{"key":"788_CR19","doi-asserted-by":"crossref","unstructured":"Roger VL. Epidemiology of heart failure. Circul Res. [Internet]. 2013 Aug 30 [cited 2025 Nov 5];113(6):646\u201359. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCRESAHA.113.300268.","DOI":"10.1161\/CIRCRESAHA.113.300268"},{"key":"788_CR20","doi-asserted-by":"crossref","unstructured":"Lam CSP, Donal E, Kraigher-Krainer E, Vasan RS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur. J. Heart Fail. [Internet]. 2011 [cited 2025 Nov 5];13(1):18\u201328. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1093\/eurjhf\/hfq121.","DOI":"10.1093\/eurjhf\/hfq121"},{"issue":"19","key":"788_CR21","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","volume":"34","author":"SJ Pocock","year":"2013","unstructured":"Pocock SJ, Ariti CA, McMurray JJV, Maggioni A, K\u00f8ber L, Squire IB, et al. Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies. Eur Heart J. 2013;34(19):1404\u201313. https:\/\/doi.org\/10.1093\/eurheartj\/ehs337.","journal-title":"Eur Heart J"},{"key":"788_CR22","doi-asserted-by":"crossref","unstructured":"Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure\u2013associated hospitalizations in the United States. JACC. [Internet]. 2013 Mar 26 [cited 2025 Nov 5];61(12):1259\u201367. https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2012.12.038.","DOI":"10.1016\/j.jacc.2012.12.038"},{"key":"788_CR23","doi-asserted-by":"crossref","unstructured":"Dunlay SM, Redfield MM, Weston SA, Therneau TM, Hall Long K, Shah ND, et al. Hospitalizations after heart failure diagnosis. JACC. [Internet]. 2009 Oct 27 [cited 2025 Nov 5];54(18):1695\u2013702. https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2009.08.019.","DOI":"10.1016\/j.jacc.2009.08.019"},{"key":"788_CR24","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. New Engl J Med. [Internet]. 2019 Nov 21 [cited 2025 Nov 5];381(21):1995\u20132008. https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1911303."},{"key":"788_CR25","doi-asserted-by":"crossref","unstructured":"Hollenberg SM, Warner Stevenson L, Ahmad T, Amin VJ, Bozkurt B, Butler J, et al. 2019 ACC Expert Consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure. JACC. [Internet]. 2019 Oct 15 [cited 2025 Nov 5];74(15):1966\u20132011. https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2019.08.001.","DOI":"10.1016\/j.jacc.2019.08.001"},{"key":"788_CR26","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. JACC. [Internet]. 2022 May 3 [cited 2025 Nov 5];79(17):e263\u2013421. https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2021.12.012."},{"key":"788_CR27","doi-asserted-by":"crossref","unstructured":"Kim HJ, Jo SH. Effect of low blood pressure on prognosis of acute heart failure. Sci Rep. [Internet]. 2024 July 6 [cited 2025 Nov 6];14(1):15605. https:\/\/www.nature.com\/articles\/s41598-024-66219-2.","DOI":"10.1038\/s41598-024-66219-2"},{"key":"788_CR28","doi-asserted-by":"crossref","unstructured":"Skouri H, Girerd N, Monzo L, Petrie MC, B\u00f6hm M, Adamo M, et al. Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. [Internet]. 2025 [cited 2025 Nov 6];27(4):707\u201322. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/ejhf.3618.","DOI":"10.1002\/ejhf.3618"},{"key":"788_CR29","doi-asserted-by":"crossref","unstructured":"Koitabashi N, Kass DA. Reverse remodeling in heart failure\u2014mechanisms and therapeutic opportunities. Nat Rev Cardiol. [Internet]. 2012 Mar [cited 2025 Nov 5];9(3):147\u201357. https:\/\/www.nature.com\/articles\/nrcardio.2011.172.","DOI":"10.1038\/nrcardio.2011.172"},{"key":"788_CR30","doi-asserted-by":"crossref","unstructured":"Irvine JC, Favaloro JL, Widdop RE, Kemp-Harper BK. Nitroxyl anion donor, Angeli\u2019s Salt, does not develop tolerance in rat isolated aortae. Hypertension. [Internet]. 2007 Apr [cited 2025 Nov 5];49(4):885\u201392. https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000259328.04159.90.","DOI":"10.1161\/01.HYP.0000259328.04159.90"},{"key":"788_CR31","doi-asserted-by":"crossref","unstructured":"Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, et al. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci. [Internet]. 2001 Aug 28 [cited 2025 Nov 5];98(18):10463\u20138. https:\/\/www.pnas.org\/doi\/full\/10.1073\/pnas.181191198.","DOI":"10.1073\/pnas.181191198"},{"key":"788_CR32","doi-asserted-by":"crossref","unstructured":"Vrtovec B, Delgado R, Zewail A, Thomas CD, Richartz BM, Radovancevic B. Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure. Circulation. [Internet]. 2003 Apr 8 [cited 2025 Nov 6];107(13):1764\u20139. https:\/\/www.ahajournals.org\/doi\/10.1161\/01.cir.0000057980.84624.95.","DOI":"10.1161\/01.CIR.0000057980.84624.95"},{"issue":"12","key":"788_CR33","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/s00392-023-02173-9","volume":"112","author":"\u00d2 Mir\u00f3","year":"2023","unstructured":"Mir\u00f3 \u00d2, Aguil\u00f3 O, Trull\u00e0s JC, Gil V, Espinosa B, Jacob J, et al. QT interval and short-term outcome in acute heart failure. Clin Res Cardiol. 2023;112(12):1754\u201365. https:\/\/doi.org\/10.1007\/s00392-023-02173-9.","journal-title":"Clin Res Cardiol"},{"key":"788_CR34","doi-asserted-by":"crossref","unstructured":"Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, et al. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. J Cardiac Fail. [Internet]. 2023 May 1 [cited 2025 Nov 6];29(5):787\u2013804. https:\/\/onlinejcf.com\/article\/S1071-9164%2823%2900064-7\/fulltext.","DOI":"10.1016\/j.cardfail.2023.02.009"},{"key":"788_CR35","doi-asserted-by":"crossref","unstructured":"Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O\u2019Connor CM, Felker GM. Troponin elevation in heart failure. JACC. [Internet]. 2010 Sept 28 [cited 2025 Nov 6];56(14):1071\u20138. https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2010.06.016.","DOI":"10.1016\/j.jacc.2010.06.016"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-026-00788-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-026-00788-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:37:02Z","timestamp":1776857822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-026-00788-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["788"],"URL":"https:\/\/doi.org\/10.1007\/s40256-026-00788-7","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors Mrunalini Dandamudi, Vinh Q.T Ho, Giang Son Arrighini, Hemank Walia, Salomon Chamay, Miguel A. Samaniego-Laguna, Juliana M. Giorgi, and Alejandro Barbagelata declare that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All authors contributed to the study\u2019s conception and design. Material preparation, data collection, and analysis were performed by [Mrunalini Dandamudi], Risk of Bias, Quality assessment, study screening and data extraction was performed by\u00a0[Vinh Q. T. Ho], [Giang Son Arrighini],\u00a0[Miguel A. Samaniego-Laguna], [Salomon Chamay], and [Hemank Walia]. The first draft of the manuscript was written by\u00a0[Mrunalini Dandamudi] and [Juliana M. Giorgi], and it was improved by [Alejandro Barbagelata]. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Not applicable. This is a meta-analysis. The Sirio Libanes Research Ethics Committee has confirmed that no ethical approval is required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The data used in this meta-analysis were extracted from publicly available sources, including published randomized controlled trials. All relevant data supporting the findings of this study are included within the manuscript and supplementary materials. Due to the nature of this analysis, no new primary data were generated. Additional details can be made available upon reasonable request to the corresponding author.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}